Feb 3, 2021 Foresee Home AMD Monitoring Program Don’t leave your vision to chance: 94% of patients using ForeseeHome maintained driving vision (20/40 or better) after their dry Macular Degeneration changed to wet. Ask us if ForeseeHome is right for you. Please click here for more information about this program:https://www.foreseehome.com/ #DetectEarly #TreatEarly #ForeseeHome #MacularDegeneration Apr 16, 2024 Treatment challenges in patients with nAMD Treatment challenges in patients with nAMD Apr 16, 2024 Data and Safety Monitoring Board (DSMB) for Ocugen’s Phase 1/2 ArMaDa clinical approves medium dose of OCU410 Data and Safety Monitoring Board (DSMB) for Ocugen’s Phase 1/2 ArMaDa clinical approves medium dose of OCU410 Apr 15, 2024 New research links vitamin D deficiency and diabetic peripheral neuropathy—but questions still remain New research links vitamin D deficiency and diabetic peripheral neuropathy—but questions still remain